tiprankstipranks
Bio-Path presents data from ongoing Phase 2 combination study of prexigebersen
PremiumThe FlyBio-Path presents data from ongoing Phase 2 combination study of prexigebersen
1M ago
Bio-Path files to sell 5.56M shares of common stock for holders
PremiumThe Fly
Bio-Path files to sell 5.56M shares of common stock for holders
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Bio-Path presents data from ongoing Phase 2 combination study of prexigebersen
PremiumThe FlyBio-Path presents data from ongoing Phase 2 combination study of prexigebersen
2M ago
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting
2M ago
Bio-Path Holdings to Present Research at Major 2024 Events
PremiumCompany Announcements
Bio-Path Holdings to Present Research at Major 2024 Events
2M ago
Bio-Path reports Q1 EPS ($4.88) vs ($13.25) last year
PremiumThe FlyBio-Path reports Q1 EPS ($4.88) vs ($13.25) last year
2M ago
BPTH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BPTH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
PremiumPress Releases
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100